Skip to main content
Explore URMC
Del Monte Institute for Neuroscience / News & Events / Institute Announcements

Institute Announcements


Del Monte Institute for Neuroscience offers 2020 pilot funds

Tuesday, February 4, 2020

The Ernest J. Del Monte Institute for Neuroscience (Del Monte) is pleased to announce the availability of up to 21 pilot project awards (maximum budget of $50,000 per award) to support novel basic, clinical and translational projects in the neurosciences. These awards will be supported under 5 programs for 2020 and are open to all faculty members across both the Medical School and the Undergraduate Campus. Funds available for this year’s program are $810,000.

The Schmitt Program in Integrative Neuroscience (SPIN) supports pilot and feasibility awards (up to $50,000 per award) for basic science and translational projects that advance our understanding of both normal and abnormal brain functioning (4-5 awards available).

The Harry T. Mangurian Jr. Foundation (MF) offers pilot and feasibility awards (up to $50,000 per award) for basic, clinical and translational projects that specifically support research on Autism Spectrum Disorder (ASD) (2 awards available).

The Rochester Center for Alzheimer’s Disease Research (RCADR) supports pilot and feasibility awards (up to $50,000 per award) for basic science and translational projects that advance our understanding of Alzheimer’s disease and related dementias (4 awards available).

Center for Health + Technology Clinical Neuroscience Pilot Program (CHET) offers pilot and feasibility awards (up to $50,000 per award) for clinical research projects that advance our understanding of areas of unmet need in clinical neuroscience (4 awards available).

University of Rochester Center for Advanced Brain Imaging and Neurophysiology (UR CABIN) offers pilot and feasibility funds (up to $10,000 per award) to support innovative, investigator-initiated basic and clinical neuroscience research using the PRISMA 3T magnet (up to 6 awards available).

For more information and to download the RFA, click here. Application submissions are due on Monday, March 16th.

Suzanne Haber Honored by Society of Biological Psychiatry for Research on Mental Disorders

Thursday, January 30, 2020

Suzanne N. Haber, Ph.D., Dean’s Professor in the Department of Pharmacology and Physiology, will receive the Society of Biological Psychiatry’s 2020 Gold Medal Award at the Society’s 75th Annual Scientific Convention & Meeting in the spring. The award honors members of the Society whose significant and sustained work has advanced and extended knowledge on the neurobiology of mental illness.

Haber’s lab investigates the cortico-cortical and cortico-basal ganglia systems in the brain. Her work demonstrates the specific hard-wired connections that are associated with normal decision making, emotional and cognitive control, and the connectional abnormalities in those circuits that are linked to a wide range of mental health disorders, including obsessive-compulsive disorder (OCD), drug abuse and addiction, schizophrenia, and motor control disorders such as Parkinson’s disease.  This work has played a key role in targeting and interpreting the effects of noninvasive and invasive therapeutic approaches for OCD and depression.

For the past ten years, Haber has led the Silvio O. Conte Center for Basic and Translational Mental Health Research at the University of Rochester. Funded by the National Institute of Mental Health, the Center uses translational approaches to probe the neurocircuitry that underlies neuromodulation for OCD, pinpointing specific abnormalities within the brain circuits that are associated with the disease. This information is being used to guide new treatment options for the three million-plus Americans who live with the disorder.

“Suzanne’s seminal contributions to elucidating specific neural networks that control learning, decision-making, reward and motivation, and how pathologies associated with these neural communication hubs underlie multiple neurological, movement, and mental health disorders make her uniquely qualified to receive this prestigious career award,” said Robert T. Dirksen, Ph.D., Lewis Pratt Ross Professor and Chair of the Department of Pharmacology and Physiology. “Her work is making a difference in the lives of individuals and families suffering from neurological and mental health disorders. We are extremely proud that she represents the University of Rochester as a Society of Biological Psychiatry Gold Medal Award winner.”

The Society of Biological Psychiatry was founded in 1945 to emphasize the medical and scientific study and treatment of mental disorders. It’s the oldest neuropsychiatry research society in America, currently made up of more than 1,500 members from across the United States, Canada, Europe and Asia. Members conduct research in areas spanning from basic cellular studies to clinical trials and prevention research.

Haber, who is also a professor of Neuroscience, Brain and Cognitive Science, and Psychiatry, will split the 2020 Gold Medal Award with Carol Tamminga, M.D. of UT Southwestern Medical Center.